BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
1292 results:

  • 1. Research progress on function and mechanism of long non-coding RNA in glioma.
    Tai F; Zhao X
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):233-237. PubMed ID: 38814211
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Optic nerve sheath diameter correlates with both success and failure of hydrocephalus treatment in pediatric patients with pineal region lesions.
    Zipfel J; Kerscher SR; Dhillon K; Ferraris KP; Singhal A
    Acta Neurochir (Wien); 2024 May; 166(1):236. PubMed ID: 38805061
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
    Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
    BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
    Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
    Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.
    Araujo-Castro M; Biagetti B; Menéndez Torre E; Novoa-Testa I; Cordido F; Pascual-Corrales E; Rodríguez Berrocal V; Guerrero-Pérez F; Vicente A; Percovich Hualpa JC; García-Centeno R; González-Fernández L; Ollero García MD; Irigaray Echarri A; Moure Rodríguez MD; Novo-Rodríguez C; Calatayud M; Villar-Taibo R; Bernabéu I; Alvarez-Escola C; Benítez Valderrama P; Tenorio-Jiménez C; Abellán Galiana P; Venegas E; González-Molero I; Iglesias P; Blanco-Carrera C; Vidal-Ostos De Lara F; de Miguel Novoa P; López Mezquita E; Hanzu FA; Aldecoa I; Aznar S; Lamas C; Aulinas A; Asla Q; Gracia Gimeno P; Recio Córdova JM; Avilés-Pérez MD; Asensio-Wandosell D; Sampedro-Núñez M; Cámara R; Paja Fano M; Ruz-Caracuel I; Fajardo C; Marazuela M; Puig-Domingo M
    Endocr Relat Cancer; 2024 Jul; 31(7):. PubMed ID: 38713182
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
    Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
    Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
    Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the met pathway in glioblastoma cells.
    Chen MS; Chong ZY; Huang C; Huang HC; Su PH; Chen JC
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38606513
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review.
    Rabelo BS; de Alvarenga KAF; Fernando Lopes L; Guimarães Ribeiro A; de Sá Rodrigues KE
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30987. PubMed ID: 38594882
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
    Straube C; Combs SE; Bernhardt D; Gempt J; Meyer B; Zimmer C; Schmidt-Graf F; Vajkoczy P; Grün A; Ehret F; Zips D; Kaul D
    J Neurooncol; 2024 May; 168(1):49-56. PubMed ID: 38520571
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
    Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
    Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
    Evans AR; Prather KY; Battiste J; Fung KM; Dunn IF; Graffeo CS
    World Neurosurg; 2024 May; 185():e1093-e1100. PubMed ID: 38490447
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
    Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
    Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
    Bagley SJ; Logun M; Fraietta JA; Wang X; Desai AS; Bagley LJ; Nabavizadeh A; Jarocha D; Martins R; Maloney E; Lledo L; Stein C; Marshall A; Leskowitz R; Jadlowsky JK; Christensen S; Oner BS; Plesa G; Brennan A; Gonzalez V; Chen F; Sun Y; Gladney W; Barrett D; Nasrallah MP; Hwang WT; Ming GL; Song H; Siegel DL; June CH; Hexner EO; Binder ZA; O'Rourke DM
    Nat Med; 2024 May; 30(5):1320-1329. PubMed ID: 38480922
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Serum sodium level fluctuations following the resection of childhood-onset craniopharyngioma.
    Miao Y; Fan K; Peng X; Li S; Chen J; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
    Brain Behav; 2024 Mar; 14(3):e3430. PubMed ID: 38433103
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome - Data from the german met studies.
    Kuhlen M; Kunstreich M; Pape UF; Seitz G; Lessel L; Vokuhl C; Frühwald MC; Vorwerk P; Redlich A
    Eur J Surg Oncol; 2024 Apr; 50(4):108051. PubMed ID: 38430702
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [
    Shahzadi I; Seidlitz A; Beuthien-Baumann B; Zwanenburg A; Platzek I; Kotzerke J; Baumann M; Krause M; Troost EGC; Löck S
    Sci Rep; 2024 Feb; 14(1):4576. PubMed ID: 38403632
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
    Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE
    Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
    Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 65.